George Bickerstaff, Director at Axovant Sciences Ltd. (AXON), bought 25,000 shares at $1.50 ($38K) on 2018-02-27, disclosed to the SEC on 2018-03-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CDNA | SELL | 2022-03-01 | $978K | — | Filing → |
| INVA | BUY | 2021-05-25 | $264K | — | Filing → |
| CDNA | SELL | 2021-05-21 | $1.5M | — | Filing → |